Roküronyuma Bağlı Hipersensitivite Reaksiyonunda Sugammadeks Kullanımı
Synopsis
This case report examines the management of a 42-year-old female patient who developed perioperative anaphylaxis characterized by sudden-onset tachycardia, hypotension, ventilation difficulty, and urticaria approximately 30 seconds after rocuronium administration for anesthetic induction prior to lumbar disc herniation surgery. Despite the administration of fluid infusion, diphenhydramine, methylprednisolone, and epinephrine, deep hypotension persisted, leading to the decision to postpone the operation and administer 200 mg intravenous sugammadex. Following sugammadex administration, a dramatic improvement in hemodynamics and respiratory functions was observed, allowing the patient to be extubated smoothly 45 minutes after induction. In the postoperative period, serum tryptase and histamine levels were elevated, and skin prick testing yielded positive results specifically for rocuronium and vecuronium. Since these two agents were deemed contraindicated, the patient underwent a successful operation 4 weeks later using cisatracurium. The report highlights that sugammadex, a modified γ-cyclodextrin, encapsulates rocuronium by binding both free and receptor-bound molecules in plasma. Although in vitro basophil activation and skin tests suggest sugammadex may not directly block histamine release, it is hypothesized to aid clinical recovery by increasing muscle tone and improving cardiac preload. Consequently, sugammadex is considered a potentially life-saving adjunct to standard anaphylaxis management in suspected rocuronium-induced hypersensitivity reactions.
References
Dong SW, Mertes PM, Petitpain N, et al. Hypersensitivity reactions during anesthesia. Results from the ninth French survey (2005-2007). Minerva Anestesiologica. 2012;78(8):868–878.
Florvaag E, Johansson SG, Oman H, et al. Prevalence of IgE antibodies to morphine. Relation to the high and low incidences of NMBA anaphylaxis in Norway and Sweden, respectively. Acta Anaesthesiologica Scandinavica. 2005 Apr;49(4):437-444.
Sadleir PH, Clarke RC, Bunning DL, et al. Anaphylaxis to neuromuscular blocking drugs: incidence and cross-reactivity in Western Australia from 2002 to 2011. British Journal of Anaesthesia. 2013;110(6):981–987.
Reddy JI, Cooke PJ, van Schalkwyk JM, et al. Anaphylaxis is more common with rocuronium and succinylcholine than with atracurium. Anesthesiology. 2015;122(1):39–45.
Johansson SG, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: Report of the nomenclature review committee of the World Allergy Organization, October 2003. Journal of Allergy and Clinical Immunology 2004;113:832-836.
Mertes PM, Malinovsky JM, Jouffroy L, et al. Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice. Journal of Investigational Allergology and Clinical Immunology. 2011;21(6):442-453.
Levy JH, Castells MC. Perioperative anaphylaxis and the United States perspective. Anesthesia & Analgesia 2011;113:979–981.
Mertes PM, Tajima K, Regnier-Kimmoun MA, et al. Perioperative anaphylaxis. Medical Clinics of North America 2010;94:761–789.
Mertes PM, Laxenaire MC, Alla F. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology. 2003 Sep;99(3):536-545.
Bom A, Bradley M, Cameron K, et al. A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angewandte Chemie International Edition. 2002;41:266–270.
Harper NJ, Dixon T, Dugue P, et al. Working Party of the Association of Anaesthetists of Great Britain and Ireland: Suspected anaphylactic reactions associated with anaesthesia. Anaesthesia 2009;64:199– 211.
Spoerl D, D'Incau S, Roux-Lombard P, et al. Non-IgE Dependent Hypersensitivity to Rocuronium Reversed by Sugammadex: Report of Three Cases and Hypothesis on the Underlying Mechanism. International Archives of Allergy and Immunology. 2016;169(4):256-262.
Jones PM, Turkstra TP. Mitigation of rocuronium-induced anaphylaxis by sugammadex: the great unknown. Anaesthesia 2010;65:89–90.
Badaoui R, Popov I, Dupont H. A case of rocuronium-induced anaphylactic shock, improved by sugammadex (in French). Canadian Journal of Anesthesia. 2012;59:909–910.
Funnell AE, Griffiths J, Hodzovic I: A further case of rocuronium-induced anaphylaxis treated with sugammadex. British Journal of Anaesthesia. 2011;107:275–276.
Kawano T, Tamura T, Hamaguchi M, et al. Successful management of rocuronium-induced anaphylactic reactions with sugammadex: a case report. Journal of Clinical Anesthesia. 2012;24:62–64.
McDonnell NJ, Pavy TJ, Green LK, et al. Sugammadex in the management of rocuronium-induced anaphylaxis. British Journal of Anaesthesia 2011;106:199–201.
Raft J, Leclercq M, Longrois D, et al. Fast recovery of haemodynamic and ventilatory functions after sugammadex bolus following rocuronium-induced anaphylactic shock refractory to conventional treatment (in French). Annales Françaises d'Anesthésie et de Réanimation 2012; 31:158–161.
Motamed C, Baguenard P, Bourgain JL. Possible mitigation of rocuronium-induced anaphylaxis after administration of sugammadex. Journal of Anaesthesiology Clinical Pharmacology 2012; 28:127–128.
Barthel F, Stojeba N, Lyons G, et al. Sugammadex in rocuronium anaphylaxis: dose matters. British Journal of Anaesthesia 2012;109: 646–647.
Sirieix D, Latreille S, Raft J. Rapid hemodynamic recovery after early epinephrine and sugammadex co-administration during rocuronium-induced anaphylactic reaction (in French). Annales Françaises d'Anesthésie et de Réanimation 2014; 33:602–603.
McNeil BD, Pundir P, Meeker S, et al. Identification of a mast-cell-specific receptor crucial for pseudo- allergic drug reactions. Nature 2015; 519:237–241.
Leysen J, Bridts CH, de Clerck LS, et al. Rocuronium-induced anaphylaxis is probably not mitigated by sugammadex: evidence from an in vitro experiment. Anaesthesia 2011; 66: 526–527.
Clarke RC, Sadleir PH, Platt PR. The role of sugammadex in the development and modification of an allergic response to rocuronium: evidence from a cutaneous model. Anaesthesia 2012; 67: 266–273.
Platt PR, Clarke RC, Johnson GH, et al. Efficacy of sugammadex in rocuronium-induced or antibiotic-induced anaphylaxis. A case-control study. Anaesthesia. 2015;70(11):1264–1267.